|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.590 CNY | +0.72% |
|
-14.79% | -24.15% |
| 02/06 | Beijing SL Pharmaceutical Co., Ltd. Approves Cash Dividend for 2025 | CI |
| 07/05 | Beijing SL Pharmaceutical Gets China Regulatory Nod for Xinfer Drug | MT |
| Market Cap | 5.74B 848M 746M 693M 637M 1.19B 82.1B 1.22B 8.28B 3.23B 40.05B 3.18B 3.11B 139B | P/E 2024 |
-107x | P/E 2025 | -21.7x |
|---|---|---|---|---|---|
| Enterprise Value | 4.6B 679M 597M 555M 510M 957M 65.79B 974M 6.64B 2.59B 32.09B 2.55B 2.5B 111B | EV / Sales 2024 |
8.62x | EV / Sales 2025 | 10.3x |
| Free-Float |
59.66% | Yield 2024 |
0.27% | Yield 2025 | 0.14% |
| 1 day | +0.72% | ||
| 1 week | -14.79% | ||
| Current month | -5.73% | ||
| 1 month | +0.90% | ||
| 3 months | -22.14% | ||
| 6 months | -28.88% | ||
| Current year | -24.15% |
| 1 week | 5.2 |  | 5.95 |
| 1 month | 4.9 | | 7.33 |
| Current year | 4.81 | | 9.4 |
| 1 year | 4.81 | | 9.4 |
| 3 years | 4.81 | | 16.09 |
| 5 years | 4.81 | | 16.09 |
| 10 years | 4.81 | | 33.03 |
| Manager | Title | Age | Since |
|---|---|---|---|
Ming Bo Xu
CEO | Chief Executive Officer | 62 | 11/04/2006 |
Li Ji
DFI | Director of Finance/CFO | 45 | 24/04/2023 |
Shu Jie Liang
SEC | Corporate Secretary | 60 | 11/04/2006 |
| Director | Title | Age | Since |
|---|---|---|---|
Ming Bo Xu
CHM | Chairman | 62 | 11/04/2006 |
Shu Jie Liang
BRD | Director/Board Member | 60 | 24/04/2009 |
Yu Lin Chen
BRD | Director/Board Member | 81 | 11/04/2006 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 5/11/25 | Buy | Director | 100 | 0.0000% | ||
| 29/10/25 | Sell | Director | 35,100 | 0.0041% | ||
| 28/10/25 | Sell | Director | 340,000 | 0.0399% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.72% | -14.79% | -29.42% | -42.13% | 842M | |
| +1.97% | +1.43% | +48.44% | +156.66% | 1,037B | |
| +1.42% | +3.72% | +53.32% | +52.34% | 615B | |
| +1.43% | +0.99% | +34.83% | +78.74% | 448B | |
| +5.14% | +5.40% | +33.75% | +27.28% | 326B | |
| +1.85% | +3.57% | +37.09% | +39.87% | 293B | |
| -0.11% | +0.48% | +18.87% | +17.81% | 264B | |
| +0.25% | -4.62% | -27.66% | -42.25% | 216B | |
| +1.49% | -0.02% | +20.14% | +58.21% | 198B | |
| +0.40% | -3.99% | +15.23% | +62.28% | 162B | |
| Average | +1.46% | -0.26% | +20.46% | +40.88% | 355.83B | |
| Weighted average by Cap. | +1.73% | +1.12% | +35.39% | +75.21% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 660M 97.5M 85.75M 79.66M 73.27M 137M 9.44B 140M 953M 372M 4.61B 366M 358M 15.98B | 624M 92.07M 80.97M 75.22M 69.19M 130M 8.92B 132M 900M 351M 4.35B 346M 338M 15.09B |
| Net income | -74.07M -10.93M -9.62M -8.93M -8.22M -15.41M -1.06B -15.69M -107M -41.67M -516M -41.05M -40.16M -1.79B | -347M -51.26M -45.08M -41.88M -38.52M -72.23M -4.96B -73.53M -501M -195M -2.42B -192M -188M -8.4B |
| Net Debt | -1.98B -293M -257M -239M -220M -412M -28.34B -420M -2.86B -1.12B -13.82B -1.1B -1.07B -47.96B | -1.14B -168M -148M -138M -127M -237M -16.32B -242M -1.65B -642M -7.96B -633M -619M -27.61B |
Employees
901
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 23/07/26 | CNY 5.590 | +0.72% | 34,374,338 |
| 22/07/26 | CNY 5.550 | -0.72% | 43,841,456 |
| 21/07/26 | CNY 5.590 | -2.44% | 61,734,142 |
| 20/07/26 | CNY 5.730 | -2.88% | 60,444,895 |
| 17/07/26 | CNY 5.900 | -10.06% | 88,365,522 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- 002038 Stock
Select your edition
All financial news and data tailored to specific country editions
